You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Herpes Simplex Virus Infection Treatment Market Research Report 2021, Competitive Analysis, Industry Growth Trends And Forecast 2027

Herpes Simplex Virus Infection is commonly known as herpes. The two types of herpes simplex virus (HSV) are HSV-1 (known to cause orofacial disease such as cold sores) and HSV-2 (causes genital infections). Over 80% of herpes infections is asymptomatic. Symptomatic infections are presented with blistering sores, pain during urination, swollen lymph nodes, and fever. The period of latency and mode of reactivation of HSV is still unclear.
Market Analysis and Insights: Global Herpes Simplex Virus Infection Treatment Market
The global Herpes Simplex Virus Infection Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Herpes Simplex Virus Infection Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Herpes Simplex Virus Infection Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Herpes Simplex Virus Infection Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Herpes Simplex Virus Infection Treatment market.
Herpes Simplex Virus Infection Treatment Breakdown Data by Type
By Type
Herpes Simplex Virus-1 (HSV-1) Infection
Herpes Simplex Virus-2 (HSV-2) Infection
HSV1 & HSV2 Co-infection
By Route of Administration
Oral
Parenteral
By Drug Molecule
Small Molecule
Vaccine
Herpes Simplex Virus Infection Treatment Breakdown Data by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Based on regional and country-level analysis, the Herpes Simplex Virus Infection Treatment market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Herpes Simplex Virus Infection Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.
The following players are covered in this report:
F. Hoffmann-La Roche Ltd
Sanofi
Teva Pharmaceuticals Inc
Merck & Co., Inc
Apotex Inc
Viatris
Epi Health LLC
Zydus Pharmaceuticals
GlaxoSmithKline LLC
Carlsbad Tech
Avet Pharmaceuticals Inc
Glenmark Pharmaceuticals
Fresenius Kabi
Agenus, Inc
Maruho Co. Ltd
AiCuris Anti-infective Cures GmbH
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Herpes Simplex Virus Infection Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Herpes Simplex Virus-1 (HSV-1) Infection
1.2.3 Herpes Simplex Virus-2 (HSV-2) Infection
1.2.4 HSV1 & HSV2 Co-infection
1.3 Market by Application
1.3.1 Global Herpes Simplex Virus Infection Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Herpes Simplex Virus Infection Treatment Market Perspective (2016-2027)
2.2 Herpes Simplex Virus Infection Treatment Growth Trends by Regions
2.2.1 Herpes Simplex Virus Infection Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Herpes Simplex Virus Infection Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Herpes Simplex Virus Infection Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Herpes Simplex Virus Infection Treatment Industry Dynamic
2.3.1 Herpes Simplex Virus Infection Treatment Market Trends
2.3.2 Herpes Simplex Virus Infection Treatment Market Drivers
2.3.3 Herpes Simplex Virus Infection Treatment Market Challenges
2.3.4 Herpes Simplex Virus Infection Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Herpes Simplex Virus Infection Treatment Players by Revenue
3.1.1 Global Top Herpes Simplex Virus Infection Treatment Players by Revenue (2016-2021)
3.1.2 Global Herpes Simplex Virus Infection Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Herpes Simplex Virus Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Herpes Simplex Virus Infection Treatment Revenue
3.4 Global Herpes Simplex Virus Infection Treatment Market Concentration Ratio
3.4.1 Global Herpes Simplex Virus Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Herpes Simplex Virus Infection Treatment Revenue in 2020
3.5 Herpes Simplex Virus Infection Treatment Key Players Head office and Area Served
3.6 Key Players Herpes Simplex Virus Infection Treatment Product Solution and Service
3.7 Date of Enter into Herpes Simplex Virus Infection Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Herpes Simplex Virus Infection Treatment Breakdown Data by Type
4.1 Global Herpes Simplex Virus Infection Treatment Historic Market Size by Type (2016-2021)
4.2 Global Herpes Simplex Virus Infection Treatment Forecasted Market Size by Type (2022-2027)

5 Herpes Simplex Virus Infection Treatment Breakdown Data by Application
5.1 Global Herpes Simplex Virus Infection Treatment Historic Market Size by Application (2016-2021)
5.2 Global Herpes Simplex Virus Infection Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Herpes Simplex Virus Infection Treatment Market Size (2016-2027)
6.2 North America Herpes Simplex Virus Infection Treatment Market Size by Type
6.2.1 North America Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2021)
6.2.2 North America Herpes Simplex Virus Infection Treatment Market Size by Type (2022-2027)
6.2.3 North America Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2027)
6.3 North America Herpes Simplex Virus Infection Treatment Market Size by Application
6.3.1 North America Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2021)
6.3.2 North America Herpes Simplex Virus Infection Treatment Market Size by Application (2022-2027)
6.3.3 North America Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2027)
6.4 North America Herpes Simplex Virus Infection Treatment Market Size by Country
6.4.1 North America Herpes Simplex Virus Infection Treatment Market Size by Country (2016-2021)
6.4.2 North America Herpes Simplex Virus Infection Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Herpes Simplex Virus Infection Treatment Market Size (2016-2027)
7.2 Europe Herpes Simplex Virus Infection Treatment Market Size by Type
7.2.1 Europe Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2021)
7.2.2 Europe Herpes Simplex Virus Infection Treatment Market Size by Type (2022-2027)
7.2.3 Europe Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2027)
7.3 Europe Herpes Simplex Virus Infection Treatment Market Size by Application
7.3.1 Europe Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2021)
7.3.2 Europe Herpes Simplex Virus Infection Treatment Market Size by Application (2022-2027)
7.3.3 Europe Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2027)
7.4 Europe Herpes Simplex Virus Infection Treatment Market Size by Country
7.4.1 Europe Herpes Simplex Virus Infection Treatment Market Size by Country (2016-2021)
7.4.2 Europe Herpes Simplex Virus Infection Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size (2016-2027)
8.2 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Type
8.2.1 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Application
8.3.1 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Region
8.4.1 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Herpes Simplex Virus Infection Treatment Market Size (2016-2027)
9.2 Latin America Herpes Simplex Virus Infection Treatment Market Size by Type
9.2.1 Latin America Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Herpes Simplex Virus Infection Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2027)
9.3 Latin America Herpes Simplex Virus Infection Treatment Market Size by Application
9.3.1 Latin America Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Herpes Simplex Virus Infection Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2027)
9.4 Latin America Herpes Simplex Virus Infection Treatment Market Size by Country
9.4.1 Latin America Herpes Simplex Virus Infection Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Herpes Simplex Virus Infection Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size (2016-2027)
10.2 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Type
10.2.1 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Application
10.3.1 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Country
10.4.1 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd
11.1.1 F. Hoffmann-La Roche Ltd Company Details
11.1.2 F. Hoffmann-La Roche Ltd Business Overview
11.1.3 F. Hoffmann-La Roche Ltd Herpes Simplex Virus Infection Treatment Introduction
11.1.4 F. Hoffmann-La Roche Ltd Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Ltd Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Herpes Simplex Virus Infection Treatment Introduction
11.2.4 Sanofi Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 Teva Pharmaceuticals Inc
11.3.1 Teva Pharmaceuticals Inc Company Details
11.3.2 Teva Pharmaceuticals Inc Business Overview
11.3.3 Teva Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Introduction
11.3.4 Teva Pharmaceuticals Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.3.5 Teva Pharmaceuticals Inc Recent Development
11.4 Merck & Co., Inc
11.4.1 Merck & Co., Inc Company Details
11.4.2 Merck & Co., Inc Business Overview
11.4.3 Merck & Co., Inc Herpes Simplex Virus Infection Treatment Introduction
11.4.4 Merck & Co., Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.4.5 Merck & Co., Inc Recent Development
11.5 Apotex Inc
11.5.1 Apotex Inc Company Details
11.5.2 Apotex Inc Business Overview
11.5.3 Apotex Inc Herpes Simplex Virus Infection Treatment Introduction
11.5.4 Apotex Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.5.5 Apotex Inc Recent Development
11.6 Viatris
11.6.1 Viatris Company Details
11.6.2 Viatris Business Overview
11.6.3 Viatris Herpes Simplex Virus Infection Treatment Introduction
11.6.4 Viatris Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.6.5 Viatris Recent Development
11.7 Epi Health LLC
11.7.1 Epi Health LLC Company Details
11.7.2 Epi Health LLC Business Overview
11.7.3 Epi Health LLC Herpes Simplex Virus Infection Treatment Introduction
11.7.4 Epi Health LLC Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.7.5 Epi Health LLC Recent Development
11.8 Zydus Pharmaceuticals
11.8.1 Zydus Pharmaceuticals Company Details
11.8.2 Zydus Pharmaceuticals Business Overview
11.8.3 Zydus Pharmaceuticals Herpes Simplex Virus Infection Treatment Introduction
11.8.4 Zydus Pharmaceuticals Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.8.5 Zydus Pharmaceuticals Recent Development
11.9 GlaxoSmithKline LLC
11.9.1 GlaxoSmithKline LLC Company Details
11.9.2 GlaxoSmithKline LLC Business Overview
11.9.3 GlaxoSmithKline LLC Herpes Simplex Virus Infection Treatment Introduction
11.9.4 GlaxoSmithKline LLC Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.9.5 GlaxoSmithKline LLC Recent Development
11.10 Carlsbad Tech
11.10.1 Carlsbad Tech Company Details
11.10.2 Carlsbad Tech Business Overview
11.10.3 Carlsbad Tech Herpes Simplex Virus Infection Treatment Introduction
11.10.4 Carlsbad Tech Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.10.5 Carlsbad Tech Recent Development
11.11 Avet Pharmaceuticals Inc
11.11.1 Avet Pharmaceuticals Inc Company Details
11.11.2 Avet Pharmaceuticals Inc Business Overview
11.11.3 Avet Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Introduction
11.11.4 Avet Pharmaceuticals Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.11.5 Avet Pharmaceuticals Inc Recent Development
11.12 Glenmark Pharmaceuticals
11.12.1 Glenmark Pharmaceuticals Company Details
11.12.2 Glenmark Pharmaceuticals Business Overview
11.12.3 Glenmark Pharmaceuticals Herpes Simplex Virus Infection Treatment Introduction
11.12.4 Glenmark Pharmaceuticals Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.12.5 Glenmark Pharmaceuticals Recent Development
11.13 Fresenius Kabi
11.13.1 Fresenius Kabi Company Details
11.13.2 Fresenius Kabi Business Overview
11.13.3 Fresenius Kabi Herpes Simplex Virus Infection Treatment Introduction
11.13.4 Fresenius Kabi Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.13.5 Fresenius Kabi Recent Development
11.14 Agenus, Inc
11.14.1 Agenus, Inc Company Details
11.14.2 Agenus, Inc Business Overview
11.14.3 Agenus, Inc Herpes Simplex Virus Infection Treatment Introduction
11.14.4 Agenus, Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.14.5 Agenus, Inc Recent Development
11.15 Maruho Co. Ltd
11.15.1 Maruho Co. Ltd Company Details
11.15.2 Maruho Co. Ltd Business Overview
11.15.3 Maruho Co. Ltd Herpes Simplex Virus Infection Treatment Introduction
11.15.4 Maruho Co. Ltd Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.15.5 Maruho Co. Ltd Recent Development
11.16 AiCuris Anti-infective Cures GmbH
11.16.1 AiCuris Anti-infective Cures GmbH Company Details
11.16.2 AiCuris Anti-infective Cures GmbH Business Overview
11.16.3 AiCuris Anti-infective Cures GmbH Herpes Simplex Virus Infection Treatment Introduction
11.16.4 AiCuris Anti-infective Cures GmbH Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.16.5 AiCuris Anti-infective Cures GmbH Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 101